MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Nonpharmacological therapies for sleep disturbances in Parkinson’s disease patients: A Systematic review

J. Lee, Y. Kim (Seoul, Republic of Korea)

Meeting: 2017 International Congress

Abstract Number: 93

Keywords: Sleep disorders. See also Restless legs syndrome: Treatment

Session Information

Date: Monday, June 5, 2017

Session Title: Parkinson's Disease: Non-Motor Symptoms

Session Time: 1:45pm-3:15pm

Location: Exhibit Hall C

Objective: To systematically review and examine the effectiveness of nonpharmacological therapies that helpful to sleep disturbances for patients with Parkinson’s disease (PD).

Background: Sleep disturbances are common non-motor symptoms in PD patients. Sleep-related symptoms include sleep fragmentations and excessive daytime sleepiness. These complaints diminish quality of life. To improve quality of sleep, nonpharmacological therapies are being raised attention because of less adverse effects compared to pharmacological treatment. However, research on nonpharmacological therapies for sleep disturbances in patients with PD is limited in quantity.

Methods: A systematic search of eight databases was conducted. Searches were supplemented by hand searching as well. Date restrictions were from January 1st, 2000 to January 1st, 2016. Our method followed PRISMA statement. Risk of bias was assessed with Cochrane Collaboration Risk of Bias Tool.

Results: A total of 8 studies were identified for data extraction. Key domain of interventions was physical interventions, cognitive interventions, and physiologic action using interventions. The most frequently used tool was Epworh Sleepiness Scale (ESS). Four of eight therapies significantly improved quality of sleep as well as other clinical symptoms of PD such as Unified Parkinson’s Disease Rating Scale (UPDRS). Other studies showed (1) no clear effect on sleep (n=1) (2) limited effect on sleep (n=1) (3) effects in both intervention and control group indicating that each intervention had no distinctive effects (n=2). As a result of assessing risk of bias for eight studies, no articles were discarded.

Conclusions: A few nonpharmacological therapies were effective in sleep complaints in PD patients. For example, a bright light therapy showed inconsistent results so that definite conclusions couldn’t be reached yet. Insufficient evidences of other therapies were attributed to unique clinical features of PD such as severity of motor symptoms, or alteration of nervous system. With continuing examining these treatment effects, nonpharmacological therapies may develop distinctive evidence to improve quality of sleep in PD patients.

To cite this abstract in AMA style:

J. Lee, Y. Kim. Nonpharmacological therapies for sleep disturbances in Parkinson’s disease patients: A Systematic review [abstract]. Mov Disord. 2017; 32 (suppl 2). https://www.mdsabstracts.org/abstract/nonpharmacological-therapies-for-sleep-disturbances-in-parkinsons-disease-patients-a-systematic-review/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/nonpharmacological-therapies-for-sleep-disturbances-in-parkinsons-disease-patients-a-systematic-review/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley